Adamis pharmaceuticals schedules first quarter 2021 financial results conference call and business update

San diego, may 12, 2021 (globe newswire) -- adamis pharmaceuticals corporation (nasdaq: admp), a biopharmaceutical company developing and commercializing specialty products for respiratory disease, allergy and opioid overdose, today announced that it will host an investor conference call on monday, may 17, 2021 at 2 p.m. pacific time to discuss its financial and operating results for the first quarter of 2021 as well as provide a business update. the company's press release concerning its first quarter 2021 financial results will be available after 1 p.m. pacific time on may 17, 2021 and on its website at www.adamispharmaceuticals.com, and the company also expects to file its quarterly report on form 10-q for the quarter ended march 31, 2021 on that date.
ADMP Ratings Summary
ADMP Quant Ranking